7 clinical trials found.
-
A Phase 1/2 Placebo-Controlled Randomized Observer-Blind Dose-Finding Study to Describe the Safety Tolerability Immunogenicity and Potential Efficacy of SARS CoV 2 RNA Vaccine Candidates Against COVID 19 in Healthy Adults
The World Health Organization (WHO) has declared COVID-19 to be a pandemic; finding a vaccine to prevent COVID-19 is an urgent need. The study will ... -
A Multicenter Adaptive Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. There are no approved medicines to treat COVID-19 ... -
Specimen Collection for Infectious Diseases with Public Health Importance
The purpose of this research study is to generate a biospecimen repository from human volunteers with suspected or confirmed, current or past infectious disease of ... -
Phlebotomy of Healthy Adults for the Purpose of Evaluation and Validation of Immune Response and Microbiology Assays
The purpose of this study is to create a bank of different types of samples. Some of these samples might be used to develop and ... -
Randomized Phase 2 Study of VE303 for Prevention of Recurrent Clostridium Difficile Infection (CONSORTIUM)
CONSORTIUM is a randomized, double-blind phase 2 study to evaluate safety, tolerability, PK/PD, and efficacy of VE303 in adult subjects with 1 or more ... -
HEP CARE Model for assessment and follow up of patients that screen positive for the Hepatitis C virus (HCV) antibody during birth cohort screening at an urban health care system in New York City; linkage and engagement in HCV Care
The purpose of this study is to determine if a hepatitis C virus (HCV) provider joining the regular care team for patients identified with HCV ... -
Phase 3 Randomized Double-Blind Placebo-Controlled Study Assessing the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2
The study is researching an experimental drug combination REGN10933 and REGN10987, given as separate subcutaneous (SC, under the skin) injections. REGN10933 and REGN10987 will sometimes ...
